A detailed history of Nomura Asset Management CO LTD transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Nomura Asset Management CO LTD holds 22,557 shares of BPMC stock, worth $2.04 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
22,557
Previous 19,816 13.83%
Holding current value
$2.04 Million
Previous $2.14 Million 2.34%
% of portfolio
0.01%
Previous 0.01%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$84.1 - $120.5 $230,518 - $330,290
2,741 Added 13.83%
22,557 $2.09 Million
Q2 2024

Aug 14, 2024

SELL
$85.18 - $108.78 $145,402 - $185,687
-1,707 Reduced 7.93%
19,816 $2.14 Million
Q1 2024

May 13, 2024

BUY
$73.17 - $99.79 $126,876 - $173,035
1,734 Added 8.76%
21,523 $2.04 Million
Q2 2022

Aug 12, 2022

SELL
$45.23 - $70.15 $369,529 - $573,125
-8,170 Reduced 29.22%
19,789 $999,000
Q1 2022

May 13, 2022

SELL
$54.1 - $110.08 $106,901 - $217,518
-1,976 Reduced 6.6%
27,959 $1.79 Million
Q4 2021

Feb 01, 2022

BUY
$94.25 - $115.99 $487,461 - $599,900
5,172 Added 20.89%
29,935 $3.21 Million
Q3 2021

Nov 12, 2021

SELL
$80.98 - $109.47 $250,066 - $338,043
-3,088 Reduced 11.09%
24,763 $2.55 Million
Q1 2021

May 14, 2021

BUY
$90.71 - $108.28 $2.53 Million - $3.02 Million
27,851 New
27,851 $2.71 Million
Q4 2020

Feb 12, 2021

BUY
$92.08 - $124.48 $0 - $0
0 New
0 $0
Q3 2020

Nov 12, 2020

BUY
$66.45 - $92.7 $0 - $0
0 New
0 $0
Q2 2020

Aug 13, 2020

BUY
$57.09 - $79.27 $0 - $0
0 New
0 $0
Q1 2020

May 14, 2020

BUY
$48.11 - $82.22 $0 - $0
0 New
0 $0
Q4 2019

Feb 13, 2020

BUY
$66.73 - $82.59 $0 - $0
0 New
0 $0
Q3 2019

Nov 13, 2019

BUY
$72.9 - $101.41 $0 - $0
0 New
0 $0
Q2 2019

Aug 13, 2019

BUY
$73.54 - $97.8 $0 - $0
0 New
0 $0
Q1 2019

May 10, 2019

BUY
$48.7 - $86.6 $0 - $0
0 New
0 $0
Q1 2019

May 10, 2019

BUY
$48.7 - $86.6 $0 - $0
0 New
0 $0
Q4 2018

Feb 12, 2019

BUY
$45.57 - $74.26 $0 - $0
0 New
0 $0
Q3 2018

Nov 07, 2018

BUY
$58.91 - $78.32 $0 - $0
0 New
0 $0
Q2 2018

Aug 03, 2018

BUY
$60.96 - $101.18 $0 - $0
0 New
0 $0
Q1 2018

May 14, 2018

BUY
$73.28 - $102.95 $0 - $0
0 New
0 $0
Q4 2017

Feb 14, 2018

BUY
$62.91 - $88.32 $0 - $0
0 New
0 $0
Q3 2017

Nov 13, 2017

BUY
$42.37 - $69.67 $0 - $0
0
0 $0

Others Institutions Holding BPMC

About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.4B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.